About the ABPI

The Association of the British Pharmaceutical Industry brings together companies in the UK that research and manufacture prescription medicines. In addition, its Research Affiliate Members are involved primarily in pharmaceutical research and
development, while General Affiliate Members are organisations with an interest in the pharmaceutical industry operating in the UK.

The ABPI provides a wide scope of services and support for its members. It represents the views of the pharmaceutical industry in England, Scotland, Wales and Northern Ireland, as well as at UK, European and international levels. We maintain close contacts with Government, politicians, academia and the media. In addition, we have developed extensive links with health managers, patient advocacy groups, training and education bodies, research councils, and professional bodies in the healthcare field.
The ABPI is the industry’s lead voice in discussions with the Government about policies in a wide range of areas. Through the provision of industry representation at the Department of Health, the Department for Business, Enterprise and Regulatory Reform, HM Treasury, the Scottish Executive, the Welsh Assembly and the Northern Ireland Assembly, issues of common interest such as health, education, training and transparency, openness and trust. science policy can be taken forward. Our objective is to maintain the UK’s pre-eminent position as a location for the discovery, development and manufacture of new medicines.
Across the UK, the ABPI undertakes activities to raise awareness of the contribution of the pharmaceutical industry, not only to the provision of healthcare within the UK, but to the wider economy. At the heart of all the ABPI’s activities lie the the benefits that patients receive from the availability of innovative and effective medicines.

For more information on the benefits of joining the ABPI please email:
membership@abpi.org.uk

Value

Establishing the UK as one of the best environments in the world for valuing and rewarding innovative medicines as cost- effective solutions for preventing and treating disease.

Innovation

Enhancing the productivity of pharmaceutical R&D, creating global centres of excellence based on academic centres, clinical research networks and the NHS patient database. Confirming the pharmaceutical industry as one of Britain’s key economic sectors.

Trust

Creating a new contract between industry and society based on integrity, honesty, knowledge, appropriate behaviours, transparency, openness and trust.

Access

Exploring new ways of ensuring the appropriate use of new medicines and setting benchmarks for their adoption in the UK.
Ensuring that throughout the UK, the right patients get the right medicine at the right time.